The same dysregulated proteins that form in the brains of patients with Alzheimer’s disease or Parkinson’s disease appear to clump within their sk... More »
Patients with advanced dementia should have increased access to comprehensive care wherever they live, including the facilities in which they spend th... More »
PHILADELPHIA – Leuprolide acetate, in combination with an acetylcholinesterase inhibitor, helped to preserve cognitive function in Alzheimer’s disease patients in an exploratory study.
The <a...
*Article updated 12/18/14
The massive $1.1 trillion spending bill that was approved by Congress before it left for an extended recess included several provisions aimed at bolstering...
Recently, an article in JAMA Internal Medicine suggested that more than 50% of nursing home patients with advanced dementia are on “medications of questionable benefit.” The <a...
Most nursing home residents with advanced dementia receive "medications of questionable benefit," given that they are terminally ill and that the goal of their care should be comfort rather...
COPENHAGEN – Detection of tau neurofibrillary tangles in the brain via PET imaging highly correlates with memory decline and could serve as an accurate way to identify individuals at high risk of...
COPENHAGEN – TDP-43, a protein that has been associated with neurodegenerative diseases such as dementia and amyotrophic lateral sclerosis, could also be contributing to brain shrinkage in...
COPENHAGEN – Losing a spouse has been associated with the broken heart syndrome and other adverse health outcomes, but the loss seems to have a paradoxical effect on the development of dementia.
An...
COPENHAGEN – Once more, an antiamyloid antibody has failed to live up to hopes for the treatment of Alzheimer’s disease.
Roche’s contender, crenezumab, faltered on all of the primary...